The first Ig domain of KIR3DL1 contacts MHC class I at a secondary site
KIR3DL1 is a highly polymorphic inhibitory killer cell Ig-like receptor (KIR) implicated in resistance to viral diseases such as AIDS. KIR3DL1 contains three Ig domains and is specific for MHC class I (MHC-I) molecules belonging to the HLA-Bw4 serogroup. The receptor's second and third Ig domai...
Gespeichert in:
Veröffentlicht in: | The Journal of immunology (1950) 2011-08, Vol.187 (4), p.1816-1825 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1825 |
---|---|
container_issue | 4 |
container_start_page | 1816 |
container_title | The Journal of immunology (1950) |
container_volume | 187 |
creator | Fu, Li Hazes, Bart Burshtyn, Deborah N |
description | KIR3DL1 is a highly polymorphic inhibitory killer cell Ig-like receptor (KIR) implicated in resistance to viral diseases such as AIDS. KIR3DL1 contains three Ig domains and is specific for MHC class I (MHC-I) molecules belonging to the HLA-Bw4 serogroup. The receptor's second and third Ig domains confer the Bw4 specificity, but the role of the first Ig domain (D0) in ligand recognition has remained enigmatic. We found that KIR3DL1 expressed in YTS cells and as a soluble receptor can weakly recognize additional MHC-I molecules including HLA-B*0702 and HLA-G. This interaction is highly sensitive to blocking with Abs to the MHC-I α3-domain and the anti-KIR3DL1 Ab Z27, but not the canonical blocking Ab DX9. Using chimeric receptors between KIR3DL1 and KIR2DL1 expressed on YTS cells and as soluble Fc-fusion proteins, we show that the D0 domain confers the broad functional recognition and binding as well as the reactivity with Z27. These results suggest that the presence of a second and independent site of interaction between D0 and MHC-I and that MHC-I could bridge KIR3DL1 molecules together in a manner that facilitates signaling. |
doi_str_mv | 10.4049/jimmunol.1002125 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_904488668</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>904488668</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-67c188b933cbe4f89d26f55c9f17649c68b806e5bfa402fdc59fd631115fad3e3</originalsourceid><addsrcrecordid>eNqFkL1PwzAQxS0EoqWwMyFvTCnnz9gjKtBGFCGhMkeOY0OqfJTYGfjvCWrLynTS3XtP934IXROYc-D6bls1zdB29ZwAUELFCZoSISCREuQpmo5LmpBUphN0EcIWACRQfo4mlKRcaimmaLn5dNhXfYg4-8Bl15iqxZ3Hz9kbe1gTbLs2GhsDflktsK1NCDjDJmKDgxtvpem_caiiu0Rn3tTBXR3mDL0_PW4Wq2T9uswW9-vEspTGRKaWKFVoxmzhuFe6pNILYbUf3-TaSlUokE4U3nCgvrRC-1IyQojwpmSOzdDtPnfXd1-DCzFvqmBdXZvWdUPINXCulJTqX6VSBFRKaToqYa-0fRdC73y-66tmbJYTyH8550fO-YHzaLk5hA9F48o_wxEs-wFAmnhP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>881087227</pqid></control><display><type>article</type><title>The first Ig domain of KIR3DL1 contacts MHC class I at a secondary site</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Fu, Li ; Hazes, Bart ; Burshtyn, Deborah N</creator><creatorcontrib>Fu, Li ; Hazes, Bart ; Burshtyn, Deborah N</creatorcontrib><description>KIR3DL1 is a highly polymorphic inhibitory killer cell Ig-like receptor (KIR) implicated in resistance to viral diseases such as AIDS. KIR3DL1 contains three Ig domains and is specific for MHC class I (MHC-I) molecules belonging to the HLA-Bw4 serogroup. The receptor's second and third Ig domains confer the Bw4 specificity, but the role of the first Ig domain (D0) in ligand recognition has remained enigmatic. We found that KIR3DL1 expressed in YTS cells and as a soluble receptor can weakly recognize additional MHC-I molecules including HLA-B*0702 and HLA-G. This interaction is highly sensitive to blocking with Abs to the MHC-I α3-domain and the anti-KIR3DL1 Ab Z27, but not the canonical blocking Ab DX9. Using chimeric receptors between KIR3DL1 and KIR2DL1 expressed on YTS cells and as soluble Fc-fusion proteins, we show that the D0 domain confers the broad functional recognition and binding as well as the reactivity with Z27. These results suggest that the presence of a second and independent site of interaction between D0 and MHC-I and that MHC-I could bridge KIR3DL1 molecules together in a manner that facilitates signaling.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.1002125</identifier><identifier>PMID: 21746965</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Antibodies, Monoclonal, Murine-Derived - immunology ; Antibodies, Monoclonal, Murine-Derived - pharmacology ; Antibodies, Neutralizing - immunology ; Antibodies, Neutralizing - pharmacology ; Binding Sites ; Cercopithecus aethiops ; COS Cells ; Histocompatibility Antigens Class I - genetics ; Histocompatibility Antigens Class I - immunology ; Histocompatibility Antigens Class I - metabolism ; Humans ; Protein Structure, Tertiary ; Receptors, KIR2DL1 - genetics ; Receptors, KIR2DL1 - immunology ; Receptors, KIR2DL1 - metabolism ; Receptors, KIR3DL1 - genetics ; Receptors, KIR3DL1 - immunology ; Receptors, KIR3DL1 - metabolism ; Recombinant Fusion Proteins - genetics ; Recombinant Fusion Proteins - immunology ; Recombinant Fusion Proteins - metabolism ; Signal Transduction - immunology</subject><ispartof>The Journal of immunology (1950), 2011-08, Vol.187 (4), p.1816-1825</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-67c188b933cbe4f89d26f55c9f17649c68b806e5bfa402fdc59fd631115fad3e3</citedby><cites>FETCH-LOGICAL-c372t-67c188b933cbe4f89d26f55c9f17649c68b806e5bfa402fdc59fd631115fad3e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21746965$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fu, Li</creatorcontrib><creatorcontrib>Hazes, Bart</creatorcontrib><creatorcontrib>Burshtyn, Deborah N</creatorcontrib><title>The first Ig domain of KIR3DL1 contacts MHC class I at a secondary site</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>KIR3DL1 is a highly polymorphic inhibitory killer cell Ig-like receptor (KIR) implicated in resistance to viral diseases such as AIDS. KIR3DL1 contains three Ig domains and is specific for MHC class I (MHC-I) molecules belonging to the HLA-Bw4 serogroup. The receptor's second and third Ig domains confer the Bw4 specificity, but the role of the first Ig domain (D0) in ligand recognition has remained enigmatic. We found that KIR3DL1 expressed in YTS cells and as a soluble receptor can weakly recognize additional MHC-I molecules including HLA-B*0702 and HLA-G. This interaction is highly sensitive to blocking with Abs to the MHC-I α3-domain and the anti-KIR3DL1 Ab Z27, but not the canonical blocking Ab DX9. Using chimeric receptors between KIR3DL1 and KIR2DL1 expressed on YTS cells and as soluble Fc-fusion proteins, we show that the D0 domain confers the broad functional recognition and binding as well as the reactivity with Z27. These results suggest that the presence of a second and independent site of interaction between D0 and MHC-I and that MHC-I could bridge KIR3DL1 molecules together in a manner that facilitates signaling.</description><subject>Animals</subject><subject>Antibodies, Monoclonal, Murine-Derived - immunology</subject><subject>Antibodies, Monoclonal, Murine-Derived - pharmacology</subject><subject>Antibodies, Neutralizing - immunology</subject><subject>Antibodies, Neutralizing - pharmacology</subject><subject>Binding Sites</subject><subject>Cercopithecus aethiops</subject><subject>COS Cells</subject><subject>Histocompatibility Antigens Class I - genetics</subject><subject>Histocompatibility Antigens Class I - immunology</subject><subject>Histocompatibility Antigens Class I - metabolism</subject><subject>Humans</subject><subject>Protein Structure, Tertiary</subject><subject>Receptors, KIR2DL1 - genetics</subject><subject>Receptors, KIR2DL1 - immunology</subject><subject>Receptors, KIR2DL1 - metabolism</subject><subject>Receptors, KIR3DL1 - genetics</subject><subject>Receptors, KIR3DL1 - immunology</subject><subject>Receptors, KIR3DL1 - metabolism</subject><subject>Recombinant Fusion Proteins - genetics</subject><subject>Recombinant Fusion Proteins - immunology</subject><subject>Recombinant Fusion Proteins - metabolism</subject><subject>Signal Transduction - immunology</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkL1PwzAQxS0EoqWwMyFvTCnnz9gjKtBGFCGhMkeOY0OqfJTYGfjvCWrLynTS3XtP934IXROYc-D6bls1zdB29ZwAUELFCZoSISCREuQpmo5LmpBUphN0EcIWACRQfo4mlKRcaimmaLn5dNhXfYg4-8Bl15iqxZ3Hz9kbe1gTbLs2GhsDflktsK1NCDjDJmKDgxtvpem_caiiu0Rn3tTBXR3mDL0_PW4Wq2T9uswW9-vEspTGRKaWKFVoxmzhuFe6pNILYbUf3-TaSlUokE4U3nCgvrRC-1IyQojwpmSOzdDtPnfXd1-DCzFvqmBdXZvWdUPINXCulJTqX6VSBFRKaToqYa-0fRdC73y-66tmbJYTyH8550fO-YHzaLk5hA9F48o_wxEs-wFAmnhP</recordid><startdate>20110815</startdate><enddate>20110815</enddate><creator>Fu, Li</creator><creator>Hazes, Bart</creator><creator>Burshtyn, Deborah N</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20110815</creationdate><title>The first Ig domain of KIR3DL1 contacts MHC class I at a secondary site</title><author>Fu, Li ; Hazes, Bart ; Burshtyn, Deborah N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-67c188b933cbe4f89d26f55c9f17649c68b806e5bfa402fdc59fd631115fad3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Antibodies, Monoclonal, Murine-Derived - immunology</topic><topic>Antibodies, Monoclonal, Murine-Derived - pharmacology</topic><topic>Antibodies, Neutralizing - immunology</topic><topic>Antibodies, Neutralizing - pharmacology</topic><topic>Binding Sites</topic><topic>Cercopithecus aethiops</topic><topic>COS Cells</topic><topic>Histocompatibility Antigens Class I - genetics</topic><topic>Histocompatibility Antigens Class I - immunology</topic><topic>Histocompatibility Antigens Class I - metabolism</topic><topic>Humans</topic><topic>Protein Structure, Tertiary</topic><topic>Receptors, KIR2DL1 - genetics</topic><topic>Receptors, KIR2DL1 - immunology</topic><topic>Receptors, KIR2DL1 - metabolism</topic><topic>Receptors, KIR3DL1 - genetics</topic><topic>Receptors, KIR3DL1 - immunology</topic><topic>Receptors, KIR3DL1 - metabolism</topic><topic>Recombinant Fusion Proteins - genetics</topic><topic>Recombinant Fusion Proteins - immunology</topic><topic>Recombinant Fusion Proteins - metabolism</topic><topic>Signal Transduction - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fu, Li</creatorcontrib><creatorcontrib>Hazes, Bart</creatorcontrib><creatorcontrib>Burshtyn, Deborah N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fu, Li</au><au>Hazes, Bart</au><au>Burshtyn, Deborah N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The first Ig domain of KIR3DL1 contacts MHC class I at a secondary site</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>2011-08-15</date><risdate>2011</risdate><volume>187</volume><issue>4</issue><spage>1816</spage><epage>1825</epage><pages>1816-1825</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>KIR3DL1 is a highly polymorphic inhibitory killer cell Ig-like receptor (KIR) implicated in resistance to viral diseases such as AIDS. KIR3DL1 contains three Ig domains and is specific for MHC class I (MHC-I) molecules belonging to the HLA-Bw4 serogroup. The receptor's second and third Ig domains confer the Bw4 specificity, but the role of the first Ig domain (D0) in ligand recognition has remained enigmatic. We found that KIR3DL1 expressed in YTS cells and as a soluble receptor can weakly recognize additional MHC-I molecules including HLA-B*0702 and HLA-G. This interaction is highly sensitive to blocking with Abs to the MHC-I α3-domain and the anti-KIR3DL1 Ab Z27, but not the canonical blocking Ab DX9. Using chimeric receptors between KIR3DL1 and KIR2DL1 expressed on YTS cells and as soluble Fc-fusion proteins, we show that the D0 domain confers the broad functional recognition and binding as well as the reactivity with Z27. These results suggest that the presence of a second and independent site of interaction between D0 and MHC-I and that MHC-I could bridge KIR3DL1 molecules together in a manner that facilitates signaling.</abstract><cop>United States</cop><pmid>21746965</pmid><doi>10.4049/jimmunol.1002125</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1767 |
ispartof | The Journal of immunology (1950), 2011-08, Vol.187 (4), p.1816-1825 |
issn | 0022-1767 1550-6606 |
language | eng |
recordid | cdi_proquest_miscellaneous_904488668 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Animals Antibodies, Monoclonal, Murine-Derived - immunology Antibodies, Monoclonal, Murine-Derived - pharmacology Antibodies, Neutralizing - immunology Antibodies, Neutralizing - pharmacology Binding Sites Cercopithecus aethiops COS Cells Histocompatibility Antigens Class I - genetics Histocompatibility Antigens Class I - immunology Histocompatibility Antigens Class I - metabolism Humans Protein Structure, Tertiary Receptors, KIR2DL1 - genetics Receptors, KIR2DL1 - immunology Receptors, KIR2DL1 - metabolism Receptors, KIR3DL1 - genetics Receptors, KIR3DL1 - immunology Receptors, KIR3DL1 - metabolism Recombinant Fusion Proteins - genetics Recombinant Fusion Proteins - immunology Recombinant Fusion Proteins - metabolism Signal Transduction - immunology |
title | The first Ig domain of KIR3DL1 contacts MHC class I at a secondary site |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A30%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20first%20Ig%20domain%20of%20KIR3DL1%20contacts%20MHC%20class%20I%20at%20a%20secondary%20site&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Fu,%20Li&rft.date=2011-08-15&rft.volume=187&rft.issue=4&rft.spage=1816&rft.epage=1825&rft.pages=1816-1825&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.1002125&rft_dat=%3Cproquest_cross%3E904488668%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=881087227&rft_id=info:pmid/21746965&rfr_iscdi=true |